Yocca Frank bought BTAI
May 4, 2026 · Form 4 insider transaction
Yocca Frank bought 17,500 shares of BioXcel Therapeutics, Inc., a transaction worth N/A. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 18 days after the transaction.
Direction
Acquired (buy-side)
Shares
17,500
Price
N/A
Total value
N/A
InsiderYocca Frank
Role—
SecurityCommon Stock
Transaction codeM: Option exercise
Transaction dateMay 4, 2026
Filing dateMay 22, 2026
Shares owned after33,020
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock.